Cargando…

A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts

BACKGROUND: Understanding the humoral immune response towards viral infection and vaccination is instrumental in developing therapeutic tools to fight and restrict the viral spread of global pandemics. Of particular interest are the specificity and breadth of antibody reactivity in order to pinpoint...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorenz, Peter, Steinbeck, Felix, Mai, Franz, Reisinger, Emil C., Müller-Hilke, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203960/
https://www.ncbi.nlm.nih.gov/pubmed/37228598
http://dx.doi.org/10.3389/fimmu.2023.1192395
_version_ 1785045743389638656
author Lorenz, Peter
Steinbeck, Felix
Mai, Franz
Reisinger, Emil C.
Müller-Hilke, Brigitte
author_facet Lorenz, Peter
Steinbeck, Felix
Mai, Franz
Reisinger, Emil C.
Müller-Hilke, Brigitte
author_sort Lorenz, Peter
collection PubMed
description BACKGROUND: Understanding the humoral immune response towards viral infection and vaccination is instrumental in developing therapeutic tools to fight and restrict the viral spread of global pandemics. Of particular interest are the specificity and breadth of antibody reactivity in order to pinpoint immune dominant epitopes that remain immutable in viral variants. METHODS: We used profiling with peptides derived from the Spike surface glycoprotein of SARS-CoV-2 to compare the antibody reactivity landscapes between patients and different vaccine cohorts. Initial screening was done with peptide microarrays while detailed results and validation data were obtained using peptide ELISA. RESULTS: Overall, antibody patterns turned out to be individually distinct. However, plasma samples of patients conspicuously recognized epitopes covering the fusion peptide region and the connector domain of Spike S2. Both regions are evolutionarily conserved and are targets of antibodies that were shown to inhibit viral infection. Among vaccinees, we discovered an invariant Spike region (amino acids 657-671) N-terminal to the furin cleavage site that elicited a significantly stronger antibody response in AZD1222- and BNT162b2- compared to NVX-CoV2373-vaccinees. CONCLUSIONS: Understanding the exact function of antibodies recognizing amino acid region 657-671 of SARS-CoV-2 Spike glycoprotein and why nucleic acid-based vaccines elicit different responses from protein-based ones will be helpful for future vaccine design.
format Online
Article
Text
id pubmed-10203960
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102039602023-05-24 A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts Lorenz, Peter Steinbeck, Felix Mai, Franz Reisinger, Emil C. Müller-Hilke, Brigitte Front Immunol Immunology BACKGROUND: Understanding the humoral immune response towards viral infection and vaccination is instrumental in developing therapeutic tools to fight and restrict the viral spread of global pandemics. Of particular interest are the specificity and breadth of antibody reactivity in order to pinpoint immune dominant epitopes that remain immutable in viral variants. METHODS: We used profiling with peptides derived from the Spike surface glycoprotein of SARS-CoV-2 to compare the antibody reactivity landscapes between patients and different vaccine cohorts. Initial screening was done with peptide microarrays while detailed results and validation data were obtained using peptide ELISA. RESULTS: Overall, antibody patterns turned out to be individually distinct. However, plasma samples of patients conspicuously recognized epitopes covering the fusion peptide region and the connector domain of Spike S2. Both regions are evolutionarily conserved and are targets of antibodies that were shown to inhibit viral infection. Among vaccinees, we discovered an invariant Spike region (amino acids 657-671) N-terminal to the furin cleavage site that elicited a significantly stronger antibody response in AZD1222- and BNT162b2- compared to NVX-CoV2373-vaccinees. CONCLUSIONS: Understanding the exact function of antibodies recognizing amino acid region 657-671 of SARS-CoV-2 Spike glycoprotein and why nucleic acid-based vaccines elicit different responses from protein-based ones will be helpful for future vaccine design. Frontiers Media S.A. 2023-05-05 /pmc/articles/PMC10203960/ /pubmed/37228598 http://dx.doi.org/10.3389/fimmu.2023.1192395 Text en Copyright © 2023 Lorenz, Steinbeck, Mai, Reisinger and Müller-Hilke https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Lorenz, Peter
Steinbeck, Felix
Mai, Franz
Reisinger, Emil C.
Müller-Hilke, Brigitte
A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts
title A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts
title_full A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts
title_fullStr A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts
title_full_unstemmed A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts
title_short A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts
title_sort linear b-cell epitope close to the furin cleavage site within the s1 domain of sars-cov-2 spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203960/
https://www.ncbi.nlm.nih.gov/pubmed/37228598
http://dx.doi.org/10.3389/fimmu.2023.1192395
work_keys_str_mv AT lorenzpeter alinearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts
AT steinbeckfelix alinearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts
AT maifranz alinearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts
AT reisingeremilc alinearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts
AT mullerhilkebrigitte alinearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts
AT lorenzpeter linearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts
AT steinbeckfelix linearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts
AT maifranz linearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts
AT reisingeremilc linearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts
AT mullerhilkebrigitte linearbcellepitopeclosetothefurincleavagesitewithinthes1domainofsarscov2spikeproteindiscriminatesthehumoralimmuneresponseofnucleicacidandproteinbasedvaccinecohorts